From: Cyclin D1 overexpression is associated with poor prognosis in oropharyngeal cancer
Total (N = 60) | Group 1a(N=39, 65%) | Group 2a(N = 21, 35%) | P value | |
---|---|---|---|---|
Mean age at diagnosis (yr ± SD) | 60.4 ± 11.7 | 59.8 ± 11.3 | 61.4 ± 12.6 | 0.63 |
Gender | ||||
Male | 46 (77) | 30 (77) | 16 (76) | |
Female | 14 (23) | 9 (23) | 5 (24) | 1 |
Smoking Habit | ||||
Non-smokers | 14 (23) | 10 (26) | 4 (19) | 0.78 |
Former smokers (quit > 5 yr) | 15 (25) | 9 (23) | 6 (29) | |
Current smokers | 29 (48) | 20 (51) | 9 (43) | |
Unknowne | 2 (3) | 0 (0) | 2 (10) | |
Alcohol b | ||||
Never or light | 51 (85) | 34 (87) | 17 (81) | 1 |
Heavy | 7 (12) | 5 (13) | 2 (10) | |
Unknowne | 2 (3) | 0 (0) | 2 (10) | |
T staging | ||||
1 | 25 (42) | 19 (49) | 6 (29) | 0.44 |
2 | 15 (25) | 9 (23) | 6 (29) | |
3 | 12 (20) | 6 (15) | 6 (29) | |
4 | 3 (5) | 2 (5) | 1 (5) | |
Unknowne | 5 (8) | 3 (8) | 2 (10) | |
N staging | ||||
N0 | 7 (12) | 6 (15) | 1 (5) | 0.4 |
N+ | 51 (85) | 32 (82) | 19 (90) | |
Unknowne | 2 (3) | 1 (3) | 1 (5) | |
TNM staging c | ||||
1 | 2 (3) | 2 (5) | 0 (0) | 0.61 |
2 | 4 (7) | 3 (8) | 1 (5) | |
3 | 11 (18) | 6 (15) | 5 (24) | |
4 | 41 (68) | 27 (69) | 14 (67) | |
Unknowne | 2 (3) | 1 (3) | 1 (5) | |
Treatment information | ||||
Surgery (S/T) only | 3 (5) | 2 (5) | 1 (5) | 0.12 |
Radiation (XRT) onlyd | 30 (50) | 18 (46) | 12 (57) | |
Chemotherapy only | 11 (18) | 5 (13) | 6 (29) | |
Combined S/T and XRT | 16 (27) | 14 (36) | 2 (10) | |
Mean Follow-Up Time (yr ± SD) | 4 ± 2.4 | 4.7 ± 2.2 | 2 ± 1.6 | < 0.0001 |